Carregant...
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases
Preliminary results demonstrated that concurrent sunitinib and stereotactic body radiation therapy (SBRT) is an active regimen for metastases limited in number and extent. This analysis was conducted to determine the long-term survival and cancer control outcomes for this novel regimen. Forty-six pa...
Guardat en:
| Publicat a: | Target Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4339281/ https://ncbi.nlm.nih.gov/pubmed/23660867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-013-0280-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|